Literature DB >> 19607922

An alternatively spliced form of glycogen synthase kinase-3beta is targeted to growing neurites and growth cones.

Alison Wood-Kaczmar1, Michaela Kraus, Koichi Ishiguro, Karen L Philpott, Phillip R Gordon-Weeks.   

Abstract

The serine/threonine kinase glycogen synthase kinase-3beta (GSK-3beta) is expressed in two, alternatively spliced, isoforms: a short form (GSK-3beta1) and a long form containing a 13 amino acid insert in the catalytic domain (GSK-3beta2). We examined the expression of these isoforms in the rat using specific antibodies and found that GSK-3beta2, in contrast to GSK-3beta1, is only expressed in the nervous system. The highest levels of GSK-3beta2 are found in the developing nervous system but expression persists into adulthood. In the adult central nervous system the highest expression of GSK-3beta2 occurs in regions with a high proportion of white matter, suggesting that GSK-3beta2 is expressed in axons. Consistent with this finding, sub-cellular fractionation of neonatal rat brain showed that GSK-3beta2 is present in fractions enriched in neurites and growth cones. Furthermore, we found that when we separated neuronal cell bodies from neurites by culturing embryonic cortical neurons in neurite outgrowth inserts, GSK-3beta2 was present in both compartments. Finally, a rabbit polyclonal antibody raised to the 13 amino acid insert of GSK-3beta2 (anti-8A) that specifically recognises GSK-3beta2, labels the cell body, including the nucleus, neurites and growth cones of embryonic neurons in culture. To compare functionally the two isoforms, we performed in vitro kinase assays. These showed that GSK-3beta1 is more efficient at phosphorylating the microtubule-associated protein MAP1B than GSK-3beta2, consistent with previous findings with the microtubule-associated protein tau. However, when co-expressed with MAP1B in COS-7 cells, both GSK-3beta isoforms equally efficiently phosphorylated MAP1B and had a similar influence on the regulation of microtubule dynamics by MAP1B in these cells. We conclude that the alternatively spliced isoform of GSK-3beta, GSK-3beta2, is neuron-specific and has overlapping activities with GSK-3beta1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19607922     DOI: 10.1016/j.mcn.2009.07.002

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  20 in total

Review 1.  GSK3 signalling in neural development.

Authors:  Eun-Mi Hur; Feng-Quan Zhou
Journal:  Nat Rev Neurosci       Date:  2010-08       Impact factor: 34.870

Review 2.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

Review 3.  PAR3-PAR6-atypical PKC polarity complex proteins in neuronal polarization.

Authors:  Sophie M Hapak; Carla V Rothlin; Sourav Ghosh
Journal:  Cell Mol Life Sci       Date:  2018-04-25       Impact factor: 9.261

4.  What Are the bona fide GSK3 Substrates?

Authors:  Calum Sutherland
Journal:  Int J Alzheimers Dis       Date:  2011-05-18

5.  Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase.

Authors:  Norelle C Wildburger; Fernanda Laezza
Journal:  Front Mol Neurosci       Date:  2012-07-16       Impact factor: 5.639

6.  Neurodevelopment in schizophrenia: the role of the wnt pathways.

Authors:  Isabella Panaccione; Flavia Napoletano; Alberto Maria Forte; Giorgio D Kotzalidis; Antonio Del Casale; Chiara Rapinesi; Chiara Brugnoli; Daniele Serata; Federica Caccia; Ilaria Cuomo; Elisa Ambrosi; Alessio Simonetti; Valeria Savoja; Lavinia De Chiara; Emanuela Danese; Giovanni Manfredi; Delfina Janiri; Marta Motolese; Ferdinando Nicoletti; Paolo Girardi; Gabriele Sani
Journal:  Curr Neuropharmacol       Date:  2013-09       Impact factor: 7.363

7.  Glycogen synthase kinase-3β: a mediator of inflammation in Alzheimer's disease?

Authors:  Jari Koistinaho; Tarja Malm; Gundars Goldsteins
Journal:  Int J Alzheimers Dis       Date:  2011-05-04

8.  Functions of GSK-3 Signaling in Development of the Nervous System.

Authors:  Woo-Yang Kim; William D Snider
Journal:  Front Mol Neurosci       Date:  2011-11-17       Impact factor: 5.639

9.  Novel reporter alleles of GSK-3α and GSK-3β.

Authors:  William B Barrell; Heather L Szabo-Rogers; Karen J Liu
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation.

Authors:  Diane P Hanger; Wendy Noble
Journal:  Int J Alzheimers Dis       Date:  2011-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.